Pabatang, Zedric Angelo .
HRN: 21-82-73 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/16/2023
CEFUROXIME 750MG (VIAL)
12/16/2023
12/22/2023
IV
370mg
Q8h
T/c UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes